149340-95-4

Upstream product

• 24954-67-4 2-(p-nitrophenyl)ethylamine 
• 149340-93-2 1-(4-nitrophenethyl)-3-propylurea 
• 149340-94-3 1-(cyanoacetyl)-3-(4-nitrophenethyl)-1-propylurea 

Downstream Products

• 149341-00-4 6-amino-1-<4-<(benzyloxycarbonyl)amino>phenethyl>-5-<(cyclopentanecarbonyl)amino>-3-propyluracil 
• 149340-98-7 6-amino-1-<4-<(benzyloxycarbonyl)amino>phenethyl>-5-nitroso-3-propyluracil 
• 149741-55-9 6-amino-1-(4-aminophenethyl)-5-<(3-noradamantylcarbonyl)amino>-3-propyluracil 
• 149741-42-4 3-(4-aminophenethyl)-8-(3-noradamantyl)-1-propylxanthine 
• 149340-99-8 5,6-diamino-1-(4-benzyloxycarbonylaminophenethyl)-3-propyluracil 
• 149744-75-2 N-{4-[2-(8-Cyclopentyl-2,6-dioxo-1-propyl-1,2,6,7-tetrahydro-purin-3-yl)-ethyl]-phenyl}-acetamide 
• 149340-97-6 6-amino-1-<4-<(benzyloxycarbonyl)amino>phenethyl>-3-propyluracil 
• 116370-30-0 [125I]-BW-A 844U 
• 149340-96-5 6-amino-1-(4-aminophenethyl)-3-propyluracil 

Relevant academic research and scientific papers

A1 ADENOSINE RECEPTOR ANTAGONISTS

Compounds of the general formula (I) are described wherein A is a 5- or 6-membered aromatic or heteroaromatic ring. Compositions comprising such compounds and methods of use thereof are also described.

Xanthine derivatives

A novel xanthine derivative of the formula (I): STR1 wherein one of R1 and R2 represents substituted or unsubstituted lower alkyl, lower alkenyl, lower alkynyl, substituted or unsubstituted alicyclic alkyl, substituted or unsubstitut

Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.

The effects of a variety of adenosine A1 and A2 antagonists on N6-((R)-phenylisopropyl)adenosine (R-PIA)- and scopolamine-induced amnesias were investigated in rodents in order to clarify the role of adenosine receptors in learning and memory. Some of the